Search results for "National health"

showing 10 items of 121 documents

The paradox of the Italian clinical embryologist in the national public health system: hints towards harmonization of a postgraduate educational curr…

2022

Clinical embryologists are highly trained laboratory professionals with multiple roles, including laboratory, clinical, biobanking and quality system management. In most European countries, clinical embryologists are trained to work in Medically Assisted Reproduction (MAR) centres without a specifically dedicated educational path. The criteria required for employment vary according to the educational structure and the public or private nature of the centre. We have herein described the educational profile required by Italian clinical embryologists to work in MAR centres of the National Health System (NHS). Public centres currently represent 36% of all the Italian MAR clinics. According to t…

medically assisted reproductionparadoxReproductive Medicinenational health systemSettore BIO/13 - Biologia ApplicataObstetrics and GynecologyGeneral MedicineSettore BIO/06 - Anatomia Comparata E CitologiaClinical embryologistHuman fertility (Cambridge, England)
researchProduct

Post-graduate medical education in public health: the case of Italy and a call for action

2017

Summary Public health technical expertise is of crucial importance to inform decision makers’ action in the field of health and its broader determinants. Improving education and training of public health professionals for both practice and research is the starting point to strengthen the role of public health so that current health challenges can be efficiently tackled. At the Association of Schools of Public Health in the European Region (ASPHER) Deans’ & Directors’ 2017 Annual Retreat, we presented the structure and management of public health training system in Italy, and we reported recent data on Italian public health specialists’ educational experience, employment opportunities and jo…

medicine.medical_specialty020205 medical informaticseducationSocio-culturale02 engineering and technologyPopulation healthEducationPublic health; Hygiene and preventive medicine; Training; Education; Survey03 medical and health sciences0302 clinical medicineHealth care0202 electrical engineering electronic engineering information engineeringMedicineTraining030212 general & internal medicineSurveySettore MED/42 - IGIENE GENERALE E APPLICATAHealth policyCommunity and Home CareMedical educationHRHISPublic healthbusiness.industrylcsh:Public aspects of medicinePublic healthEnvironmental and Occupational HealthEducation; Hygiene and preventive medicine; Public health; Survey; TrainingPublic Health Environmental and Occupational HealthInternational healthEducation; Hygiene and preventive medicine; Public health; Survey; Training; Community and Home Care; Public Health Environmental and Occupational Healthlcsh:RA1-1270Hygiene and preventive medicinePublic health informaticsHealth promotionCommentarybusiness
researchProduct

The Child Health Care System in Italy

2016

Pediatric care in Italy has been based during the last 40 years on the increased awareness of the importance of meeting the psychosocial and developmental needs of children and of the role of families in promoting the health and well-being of their children. The pediatric health care system in Italy is part of the national health system. It is made up of 3 main levels of intervention: first access/primary care, secondary care/hospital care, and tertiary care based on specialty hospital care. This overview will also include a brief report on neonatal care, pediatric preventive health care, health service accreditation programs, and postgraduate training in pediatrics. The quality of the Ital…

medicine.medical_specialtyAdolescentChild Health ServicesvaccinationsHealth administration03 medical and health sciences0302 clinical medicineAmbulatory careNursingchildren030225 pediatricsHealth caremedicineHumans030212 general & internal medicinehospitalChildUnlicensed assistive personnelHealth policyHRHIShealth care systembusiness.industryPublic healthpublic healthInternational healthInfantpediatric carechildren careItalychildren care; hospital; public health; vaccinationsSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAChild PreschoolPediatrics Perinatology and Child Healthbusiness
researchProduct

Aspects of excessive antibiotic consumption and environmental influences correlated with the occurrence of resistance to antimicrobial agents

2021

International audience; This article explores the correlation between specific aspects of antibiotic usage, their resistance development, and environmental factors. The indiscriminate use of antibiotics led to environment contamination, selection and spreading of antibiotic-resistant organisms, and alteration of the microbial ecosystems balance. Sociobehavioural environmental factors and changes in the natural environment are major contributors to resistance development. Resistant bacteria strains' isolation in food, water, soil etc. demonstrates the environmental influence on the strains through antibiotics accumulation in the environment. It is difficult to assess the impact of antibiotic…

medicine.medical_specialtyAntibiotic resistancemedicine.drug_classHealth Toxicology and Mutagenesis0208 environmental biotechnologyAntibiotics02 engineering and technology010501 environmental sciencesBiologyExcessive antibiotic consumption01 natural sciencesAntibiotic resistanceEnvironmental factorsmedicineEnvironmental ChemistryEcosystem0105 earth and related environmental sciences2. Zero hungerResistance (ecology)business.industryPublic healthPublic Health Environmental and Occupational HealthInternational healthContaminationAntimicrobial6. Clean water020801 environmental engineering3. Good healthBiotechnologyHealth13. Climate action[SDE]Environmental SciencesbusinessCurrent Opinion in Environmental Science & Health
researchProduct

Position Paper on Young Vascular Surgeons Training of the Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS): State of the Art a…

2021

ABSTRACT The Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS) was founded in 2018, with the aim to promote cooperation among vascular professionals within Mediterranean countries. Due to its prominent social and economic impact on national health systems, diabetic peripheral artery was selected as the very first topic to be investigated by the federation. In this second paper, different experiences from delegates of participating countries were shared to define common strategies to harmonize, standardize, and optimize education and training in the Vascular Surgery specialty.

medicine.medical_specialtyArterial diseasemedia_common.quotation_subjectVascular SurgerySettore MED/22 - Chirurgia VascolareTraining (civil)Peripheral Arterial DiseaseState (polity)medicineMediterranean SeaHumansTrainingEconomic impact analysisVascular surgery specialtymedia_commonNational healthSurgeonsbusiness.industryMediterranean RegionInternship and ResidencyGeneral MedicineVascular surgeryendovascular surgery; Mediterranean sea; training; vascular surgeryEducation Medical GraduateFamily medicineEndovascular SurgeryPosition paperSurgeryClinical CompetenceCurriculumCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresDiabetic AngiopathiesLearning CurveProgram EvaluationSpecialization
researchProduct

El papel desempeñado por los programas país de la Organización Mundial de la Salud en el desarrollo de la virología en España, 1951-1975

2020

Abstract Within the framework of recent historiography about the role of the World Health Organization (WHO) in modernizing public health and the multifaceted concept of global health, this study addresses the impact of the WHO’s “country programs” in Spain from the time it was admitted to this organization in 1951 to 1975. This research adopts a transnational historical perspective and emphasizes attention to the circulation of health knowledge, practices, and people, and focuses on the Spain-0001 and Spain-0025programs, their role in the development of virology in Spain, and the transformation of public health. Sources include historical archives (WHO, the Spanish National Health School),…

medicine.medical_specialtyBiomedical ResearchEspañaMEDLINEHealth knowledgetwentieth centuryWorld Health OrganizationWorld healthvirología060104 historyHistory and Philosophy of Sciencesalud públicaPolitical scienceGlobal healthmedicineHumans0601 history and archaeologyOrganización Mundial de la Salud (OMSHistory of medicine. Medical expeditionsR131-687National healthWorld Health Organization (WHOPublic healthpublic healthHistoriography06 humanities and the artsGeneral MedicineHistory 20th CenturyVirologyvirology060105 history of science technology & medicineSpainPublic Health Practicesiglo XX
researchProduct

Clinical management of drug-drug interactions in HCV therapy: Challenges and solutions.

2013

Contains fulltext : 118153.pdf (Publisher’s version ) (Open Access) Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other co-morbidities. Drug-drug interactions associated with this polypharmacy are relatively new to the field of HCV pharmacotherapy. With the advent of the direct-acting antivirals telaprevir and boceprevir, which are both substrates and inhibitors of the cytochrome P450 (CYP) 3A iso-enzyme, knowledge and awareness of drug-drug interactions have become a cornerstone in the evaluation of patients starting and continuing HCV combination therapy. In our opinion, an overview of conducted dr…

medicine.medical_specialtyCombination therapyPharmacologyAntiviral AgentsDrug interactionsTelaprevirTelaprevirchemistry.chemical_compoundPharmacotherapyAnti-Infective AgentsBoceprevirOpiate Substitution TreatmentmedicineHumansHypnotics and SedativesHypoglycemic AgentsPharmacokineticsSummary of Product CharacteristicsIntensive care medicineAdverse effectPolypharmacyBoceprevirHepatologybusiness.industryHCV therapyCardiovascular AgentsHepatitis C ChronicAntidepressive AgentsBuprenorphinechemistryCardiovascular agentHepatitis C virus infectionDrug Therapy CombinationHydroxymethylglutaryl-CoA Reductase InhibitorsPoverty-related infectious diseases Infectious diseases and international health [N4i 3]businessImmunosuppressive AgentsMethadonemedicine.drug
researchProduct

Quo vadis SANEPID? A cross-country analysis of public health reforms in 10 post-Soviet states

2010

Abstract Background The public health systems of the post-Soviet states have evolved from the san-epid system, which dominated public health practice throughout the former Soviet Union. Since independence, reforms have taken different directions. This article provides a cross-country comparison of public health reform processes and contents in 10 post-Soviet states. Methods The study is descriptive and comparative, based on a literature review of the major health databases, the Health Systems in Transition (HiT) volumes and grey literature. Search terms included terms on public health, the san-epid services and organizational reforms in one or several post-Soviet states. Results Public heal…

medicine.medical_specialtyEconomic growthAzerbaijanRepublic of BelarusHealth PromotionPublic administrationGeorgia (Republic)medicineHumansPost-Soviet statesKyrgyzstanHealth policybusiness.industryHealth PolicyPublic healthInternational healthUzbekistanGrey literatureArmeniaMoldovaKazakhstanSiberiaHealth promotionHealth Care ReformPreventive MedicineIntersectoral CollaborationUkrainebusinessPublic Health AdministrationStrengths and weaknessesHealth Policy
researchProduct

Rare diseases and orphan drugs: Latvian story

2014

Background Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in the public health system, though there are significant differences in the national healthcare services for rare diseases among the EU States. This study aims to determine situation in the field of rare diseases in Latvia and compare it with other European countries. Methods We used the national plan for rare diseases, EUCERD reports, Orphanet data, Latvian and European regulations, publicly availa…

medicine.medical_specialtyEconomic growthNational Health ProgramsOrphan Drug ProductionLegislationReviewPharmacologyOrphan drugRare DiseasesPolitical scienceOrphan Drug ProductionHealth caremedicineMember stateHumansOrphan drugsGenetics(clinical)Pharmacology (medical)Genetics (clinical)Medicine(all)business.industryPublic healthLatvianAvailabilityLegislatureGeneral MedicineLegislation DrugAccessibilityLatvialanguage.human_languageEuropelanguagebusinessOrphanet Journal of Rare Diseases
researchProduct

Hipercolesterolemia familiar homocigota: adaptación a España del documento de posición del grupo de consenso sobre hipercolesterolemia familiar de la…

2015

Homozygous familial hypercholesterolaemia (HoFH) is a rare life-threatening disease characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol (LDL-C) and accelerated, premature atherosclerotic cardiovascular disease (ACVD). The Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (EAS) has recently published a clinical guide to diagnose and manage HoFH (Eur Heart J. 2014;35:2146-57). Both the Spanish Society of Atherosclerosis (SEA) and Familial Hypercholesterolaemia Foundation (FHF) consider this European Consensus document of great value and utility. However, there are particularities in our country which advise to ha…

medicine.medical_specialtyEzetimibeHomozygous familial hypercholesterolaemiaDiagnosisMedicinePharmacology (medical)Lipoprotein cholesterolNational healthEzetimibabusiness.industryAtherosclerotic cardiovascular diseaseDiagnósticoAféresisStatinsHipercolesterolemia familiar homocigotaLomitapidaEzetimibeLomitapidePatient managementLDL apheresisFamily medicineEuropean atherosclerosis societylipids (amino acids peptides and proteins)ApheresisCardiology and Cardiovascular MedicinebusinessEstatinasmedicine.drug
researchProduct